<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Harr MW</submitter><funding>NCI NIH HHS</funding><pagination>165-177</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10569261</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(3)</volume><pubmed_abstract>There is increasing evidence that the T-cell protein, Lck, is involved in the pathogenesis of chronic lymphocytic leukemia (CLL) as well as other leukemias and lymphomas. We previously discovered that Lck binds to domain 5 of inositol 1,4,5-trisphosphate receptors (IP&lt;sub>3&lt;/sub>R) to regulate Ca&lt;sup>2+&lt;/sup> homeostasis. Using bioinformatics, we targeted a region within domain 5 of IP&lt;sub>3&lt;/sub>R-1 predicted to facilitate protein-protein interactions (PPIs). We generated a synthetic 21 amino acid peptide, KKRMDLVLELKNNASKLLLAI, which constitutes a domain 5 sub-domain (D5SD) of IP&lt;sub>3&lt;/sub>R-1 that specifically binds Lck via its SH2 domain. With the addition of an HIV-TAT sequence to enable cell permeability of D5SD peptide, we observed wide-spread, Ca&lt;sup>2+&lt;/sup>-dependent, cell killi</pubmed_abstract><journal>Archives of microbiology &amp; immunology</journal><pubmed_title>A Novel Peptide that Disrupts the Lck-IP&lt;sub>3&lt;/sub>R Protein-Protein Interaction Induces Widespread Cell Death in Leukemia and Lymphoma.</pubmed_title><pmcid>PMC10569261</pmcid><funding_grant_id>R01 CA042755</funding_grant_id><funding_grant_id>T32 CA059366</funding_grant_id><pubmed_authors>Harr MW</pubmed_authors><pubmed_authors>Haberer B</pubmed_authors><pubmed_authors>Zhong F</pubmed_authors><pubmed_authors>Aldabbagh K</pubmed_authors><pubmed_authors>Yee V</pubmed_authors><pubmed_authors>Lavik A</pubmed_authors><pubmed_authors>McColl K</pubmed_authors><pubmed_authors>Distelhorst CW</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Novel Peptide that Disrupts the Lck-IP&lt;sub>3&lt;/sub>R Protein-Protein Interaction Induces Widespread Cell Death in Leukemia and Lymphoma.</name><description>There is increasing evidence that the T-cell protein, Lck, is involved in the pathogenesis of chronic lymphocytic leukemia (CLL) as well as other leukemias and lymphomas. We previously discovered that Lck binds to domain 5 of inositol 1,4,5-trisphosphate receptors (IP&lt;sub>3&lt;/sub>R) to regulate Ca&lt;sup>2+&lt;/sup> homeostasis. Using bioinformatics, we targeted a region within domain 5 of IP&lt;sub>3&lt;/sub>R-1 predicted to facilitate protein-protein interactions (PPIs). We generated a synthetic 21 amino acid peptide, KKRMDLVLELKNNASKLLLAI, which constitutes a domain 5 sub-domain (D5SD) of IP&lt;sub>3&lt;/sub>R-1 that specifically binds Lck via its SH2 domain. With the addition of an HIV-TAT sequence to enable cell permeability of D5SD peptide, we observed wide-spread, Ca&lt;sup>2+&lt;/sup>-dependent, cell killi</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-04-26T15:10:01.779Z</modification><creation>2024-11-21T09:48:19.787Z</creation></dates><accession>S-EPMC10569261</accession><cross_references><pubmed>37829571</pubmed><doi>10.26502/ami.936500114</doi></cross_references></HashMap>